PubMed Health⌕ Search

Biomedical subjects

A Koivula

Publications and source records attributed to A Koivula.

At least 37 records · Page 2Linked to original sources

The active site of Trichoderma reesei cellobiohydrolase II: the role of tyrosine 169.

Trichoderma reesei cellobiohydrolase II (CBHII) is an exoglucanase cleaving primarily cellobiose units from the non-reducing end of cellulose chains. The beta-1,4 glycosidic bond is cleaved by acid catalysis with an aspartic acid, D221, as the likely proton donor, and another aspartate, D175, probably ensuring its protonation and stabilizing charged reaction intermediates. The catalytic base has not yet been identified experimentally. The refined crystal structure of CBHII also shows a tyrosine residue, Y169, located close enough to the scissile bond to be involved in catalysis. The role of this residue has been studied by introducing a mutation Y169F, and analysing the kinetic and binding behavior of the mutated CBHII. The crystal structure of the mutated enzyme was determined to 2.0 A resolution showing no changes when compared with the structure of native CBHII. However, the association constants of the mutant enzyme for cellobiose and cellotriose are increased threefold and for 4-methylumbelliferyl cellobioside over 50-fold. The catalytic constants towards cellotriose and cellotetraose are four times lower for the mutant. These data suggest that Y169, on interacting with a glucose ring entering the second subsite in a narrow tunnel, helps to distort the glucose ring into a more reactive conformation. In addition, a change in the pH activity profile was observed. This indicates that Y169 may have a second role in the catalysis, namely to affect the protonation state of the active site carboxylates, D175 and D221.

Binding Sites↗

Immunoaffinity Chromatographic Purification of Cellobiohydrolase II Mutants from Recombinant Trichoderma reesei Strains Devoid of Major Endoglucanase Genes

Efficient purification of Trichoderma reesei cellobiohydrolase II (CBHII) requires the use of affinity chromatography based on a substrate analogue. Due to altered substrate binding, the purification of many active-site mutants of CBHII from the complex fungal culture media represents a considerable challenge. Here we describe a combination of two approaches to facilitate the purification: the first is based on the construction of novel engineered T. reesei strains devoid of the major contaminating endoglucanases, and the second uses immunoaffinity chromatography as the final purification step. Two different procedures for the preparation of the antibody matrix were tested. Crosslinking of the monoclonal antibody to Protein G matrix instead of the conventional immobilization via cyanogen bromide increased the binding efficiency. Three different active-site mutants of CBHII bound to the immunoaffinity column in neutral pH and were eluted in pH 2.7. The purity of the CBHII mutant preparations was tested using small chromophoric substrates and hydroxyethyl cellulose, which are hydrolyzed by many other cellulases but not by CBHII. The immunoaffinity column purified the CBHII mutants over 800-fold in a single step and resulted in homogeneous protein preparations free of proteolytically cleaved forms of CBHII. The use of the double replacement T. reesei production strains, especially the one lacking the genes coding for both the endogeneous CBHII and the endoglucanase II (EGII), helped to reduce the total endoglucanase activity in the preparations.

Journal Article↗

Immunoaffinity chromatographic purification of cellobiohydrolase II mutants from recombinant trichoderma reesei strains devoid of major endoglucanase genes.

Efficient purification of Trichoderma reesei cellobiohydrolase II (CBHII) requires the use of affinity chromatography based on a substrate analogue. Due to altered substrate binding, the purification of many active-site mutants of CBHII from the complex fungal culture media represents a considerable challenge. Here we describe a combination of two approaches to facilitate the purification: the first is based on the construction of novel engineered T. reesei strains devoid of the major contaminating endoglucanases, and the second uses immunoaffinity chromatography as the final purification step. Two different procedures for the preparation of the antibody matrix were tested. Crosslinking of the monoclonal antibody to Protein G matrix instead of the conventional immobilization via cyanogen bromide increased the binding efficiency. Three different active-site mutants of CBHII bound to the immunoaffinity column in neutral pH and were eluted in pH 2.7. The purity of the CBHII mutant preparations was tested using small chromophoric substrates and hydroxyethyl cellulose, which are hydrolyzed by many other cellulases but not by CBHII. The immunoaffinity column purified the CBHII mutants over 800-fold in a single step and resulted in homogeneous protein preparations free of proteolytically cleaved forms of CBHII. The use of the double replacement T. reesei production strains, especially the one lacking the genes coding for both the endogeneous CBHII and the endoglucanase II (EGII), helped to reduce the total endoglucanase activity in the preparations.

Binding Sites↗

Progress-curve analysis shows that glucose inhibits the cellotriose hydrolysis catalysed by cellobiohydrolase II from Trichoderma reesei.

NMR spectroscopy and HPLC were used to investigate the hydrolysis of cellotriose by cellobiohydrolase II from Trichoderma reesei. Substrate and product concentrations were followed as a function of time. Progress curves were calculated by forward numerical integration of the full kinetic equations and were fitted to the experimental data. Binding and rate constants were obtained from this fit, whereby no initial slope or Michaelis-Menten approximation was used. The progress curves from a single experiment sufficed to produce agreement with the Michaelis-Menten model (eight experiments). The absence of a kinetic isotope effect was proven. The progress-curve analysis showed that a simple degradation model cannot describe the experimental time-courses at substrate concentrations greater than 1 mM. A model containing competitive inhibition from cellobiose as well as non-competitive inhibition from glucose was developed. This four-parameter model accurately reproduces about 1000 experimental data points covering five orders of magnitude in oligosaccharide concentrations. Glucose binding to the enzyme/cellotriose complex retards, in a non-competitive fashion, cellotriose hydrolysis by at least a factor of 30. A structural model for the non-competitive inhibition is discussed. The NMR experiment also produced individual progress curves for the alpha and beta anomers. The beta anomer of cellotriose was degraded 2.5-times faster than the alpha anomer.

Catalysis↗

Intracavitary irradiation of endometrial cancer of large uteri using a two-phase afterloading technique.

A specific intracavitary two-phase technique was developed for irradiation of endometrial cancer located in uteri with a large uterine cavity. In this technique an insertion catheter (external diameter 9 mm) was used for the introduction and precise location of the treatment catheter (external diameter 6.4 mm). During the first phase of the therapy, one lateral half of the uterine body was irradiated. Thereafter the positions of the catheters were changed by 180 degrees, followed by irradiation of the other lateral half of the uterine body. Using a wax phantom and extirpated uteri as models, we observed that the dose distributions followed the uterine shape and the calculated doses in the radiographs. Clinical observations from 34 patients treated so far, and followed-up for periods of 3 months to 6 years, prove that this method yields similar results to those observed in previous studies employing the Heyman packing method or afterloading techniques with a one-source tandem in the intracavitary irradiation of endometrial cancer.

Brachytherapy↗

Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia.

The effect of intravenously administered labetalol (1 mg/kg) on placental and fetal blood flow was studied in 13 pre-eclamptic women. Although the maternal blood pressure decreased, no changes occurred in the blood flows in the intervillous space, the umbilical vein or the fetal descending aorta, nor did the indices of peripheral vascular resistance in the fetal aorta change, but the placental vascular resistance did decrease. Labetalol had no effect on prostacyclin or thromboxane A2 as measured by urinary 6-keto-prostaglandin F1 alpha and serum thromboxane B2 respectively. These findings are clinically relevant since they suggest that labetalol reduces maternal blood pressure without interfering with the placental or fetal blood flow.

Blood Pressure↗

Ritodrine infusion during late pregnancy: effects on fetal and placental blood flow, prostacyclin, and thromboxane.

To study the effects of ritodrine on fetal and placental blood flow and maternal prostacyclin and thromboxane A2, 14 women with premature uterine contractions between the thirty-first and thirty-sixth weeks of pregnancy were treated with intravenous infusions of ritodrine, with incremental doses up to 200 micrograms per minute. The intervillous and the umbilical vein blood flows were measured before and after 1 hour of infusion of ritodrine, with the xenon 133 method and with a combination of real-time and Doppler ultrasonic equipment, respectively. Ritodrine decreased maternal diastolic and mean arterial pressures, as well as placental vascular resistance, but caused no significant changes in intervillous and umbilical vein blood flows. Ritodrine stimulated the synthesis of vasodilatory prostacyclin, as seen from a rise in maternal plasma 6-keto-prostaglandin F1 alpha, but inhibited the platelets' capacity to generate the vasoconstrictor thromboxane A2. Thus, apart from maternal hemodynamic changes, the intervillous and umbilical circulations are maintained during short-term administration of ritodrine in normotensive pregnancies.

6-Ketoprostaglandin F1 alpha↗

Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia.

Seven patients with acute preeclampsia and six with superimposed preeclampsia were infused intravenously with incremental doses of prostacyclin (up to 8 ng/min/kg during 80 minutes). Prostacyclin infusion was accompanied by significant decreases in maternal blood pressure and consistent rises in maternal plasma or urinary 6-keto-prostaglandin F1 alpha, but it caused no changes in maternal or fetal pulse rate or uterine contractility. Moreover, prostacyclin did not change the placental and umbilical blood flow, which were measured before and at the end of infusion. All women experienced facial flushing and two complained of headache during infusion. There was no difference in prostacyclin effects between women with acute or superimposed preeclampsia. These results may be taken as evidence that intravenous prostacyclin is not a specific therapy to increase placental or umbilical blood flow in preeclampsia.

6-Ketoprostaglandin F1 alpha↗

Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids.

The hemodynamic effects of intravenously infused dihydralazine (incremental doses up to 125 micrograms per minute during 60 minutes) were studied in ten women with acute or superimposed severe preeclampsia. The intervillous and umbilical vein blood flow were measured before and during dihydralazine infusion with 133Xenon method and with a combination of real-time and Doppler ultrasonic equipment, respectively. Maternal blood pressure decreased and pulse rate increased during the infusion. Dihydralazine did not change the intervillous blood flow but it increased the blood flow in umbilical vein. No effect on the 6-ketoprostaglandin F1 alpha in maternal plasma and urine or thromboxane B2 in maternal serum was observed. The results indicate that dihydralazine affects the placental and fetal circulations differently.

6-Ketoprostaglandin F1 alpha↗

Placental blood flow during caesarean section performed under subarachnoid blockade.

Subarachnoid blockade using 0.5% bupivacine after a "preload" of Ringer's lactate solution 1500-2000 ml i.v. was studied in nine patients undergoing elective Caesarean section. Ephedrine infusion 50 mg in 500 ml was instituted at the first signs of maternal hypotension in seven patients. Although significant decreases in mean maternal systolic, mean and diastolic arterial pressures were recorded, the individual decreases in pressure were less than 30 mm Hg in all except two patients. In general placental blood flow did not change, although there was a marked increase in one patient with toxaemia and a decrease in one woman with diabetes mellitus. The babies were unaffected at delivery. Preventive measures, especially the "preload" infusion, are important in the maintenance of adequate placental perfusion in patients undergoing Caesarean section under subarachnoid blockade.

Adult↗

Intervillous blood flow during caesarean section with prophylactic ephedrine and epidural anaesthesia.

We administered a 15 mg i.v. bolus of ephedrine at the commencement of epidural blockade to nine healthy parturients scheduled for elective caesarean section. Nine other patients did not receive prophylactic ephedrine before epidural anaesthesia (control group). Lactated Ringer solution, 30 ml/kg, was infused before and during blockade, and left uterine displacement was used to minimize aortocaval compression. A133Xe i.v. technique was used to measure intervillous blood flow (IBF) before and 20-25 min after epidural block. The mean arterial pressure (MAP) decreased after epidural blockade in the ephedrine group by 0.67 +/- 0.8 (mean +/- s.d.) kPa and by 1.20 +/- 1.1 (mean +/- s.d.) kPa in the control group. In spite of the decrease in MAP, IBF increased by 6% in patients receiving ephedrine (N.S.), whereas it decreased by 11% in the control group (N.S.). In the ephedrine group there was in this preliminary study a trend to increasing IBF during falling perfusion pressure (MAP). The results of this preliminary study suggest that ephedrine will not affect IBF, but to prevent maternal hypotension ephedrine should be used as an i.v. infusion instead of a bolus injection.

Adult↗

The effect of caffeine on placental and fetal blood flow in human pregnancy.

The effects of maternal ingestion of two cups of coffee were investigated in 20 pregnancies during the last trimester. Maternal serum caffeine and epinephrine concentrations after 30 minutes were significantly elevated as compared with the fasting values (p less than 0.01). The intervillous placental blood flow decreased almost significantly (p less than 0.05). The fetal umbilical vein blood flow was unchanged. In patients with hypertensive pregnancy in the series there was reduced intervillous blood flow initially, and these values did not change after the maternal caffeine intake. The decrease of placental blood supply and increased maternal serum epinephrine levels associated with maternal coffee ingestion may be potential perinatologic risks, and more investigation about caffeine effects in human pregnancy is needed.

Blood Pressure↗

The influence of maternal oxygen inhalation on human placental and umbilical venous blood flow.

The effect of maternal short-term inhalation of oxygen (51/min) on intervillous (IVBF) and umbilical vein blood flow (UVBF) was studied in 22 cases during the third trimester of pregnancy. The maternal paO2 levels increased significantly (P less than 0.001) after O2 inhalation. The mean IVBF level was 190 +/- 66 (SD) ml/min per 100 ml of the intervillous space before inhalation and 125 +/- 58 ml afterwards, the decrease being significant (P less than 0.01). UVBF maintained its original level after O2 inhalation. The human fetus seems not to compensate for alterations in oxygen delivery and reduced IVBF after maternal oxygen inhalation, by means of changes in UVBF.

Female↗

Albumin infusion does not alter the intervillous blood flow in severe pre-eclampsia.

Intervillous blood flow (IVBF) was measured by the 133Xe intravenous method before and after a 100 ml infusion of 20% human albumin in 13 cases of severe pre-eclampsia. In spite of the significant increase in serum albumin and colloid osmotic pressure values, no parallel direction of change in IVBF values could be seen to result from the immediate effects of volume expansion therapy. The results suggest that the use of albumin infusion is of no specific value in the treatment of severe pre-eclampsia in terms of evaluation at the level of placental circulation. The observation of an increase in placental blood flow in cases of real hypoalbuminemia calls for a further elucidation.

Albumins↗

The spin-lattice relaxation time in the blood of healthy subjects and patients with malignant blood disease.

To establish which constituents of blood influence the NMR relaxation time T1 of water protons in malignant blood diseases, 55 blood samples were studied (20 from healthy donors and 35 from patients with leukaemia, myelofibrosis and multiple myeloma). Relaxation time measurements were performed at 19.8 MHz resonance frequency and at a temperature of 33 +/- 1 degree C. There is a significant elevation of T1 over the normal level in whole blood, packed cells, and plasma of patients with blood disease. The relaxation rate R1 (= 1/T1) depends very strongly on the ratio of dry solids to water, which is in accordance with the three-state fast-exchange relaxation model.

Blood Physiological Phenomena↗

Effect of extradural analgesia using bupivacaine and 2-chloroprocaine on intervillous blood flow during normal labour.

The effect of lumbar extradural analgesia on intervillous blood flow (IBF) during labour was studied in 26 healthy parturients using an i.v. bolus injection of xenon-133. There was a 19% decrease (n.s.) in mean IBF in six parturients (non-extradural control group). Mean IBF increased by 37.5% when 0.25% bupivacaine 10 ml was used and by 35.2% when 2% 2-chloroprocaine 10 ml was used (n.s.). When the two extradural groups were combined, the mean difference between IBF1 and IBF2 was 45 +/- 112 ml min-1 dl-1. This increase is statistically significant (P less than 0.05). The improvement in IBF after extradural block was considered to be a result of the decreased uterine vascular resistance, as no significant changes were observed in arterial pressure, uterine activity or uterine tone.

Adult↗

99mTc-DTPA--a useful clinical tool for the measurement of glomerular filtration rate.

The single injection 99mTc-DTPA clearance was compared with the inulin clearance performed with the constant infusion technique in 22 subjects. There was a good correlation between these two methods (r = 0.968, p less than 0.001). Although the single injection technique calculated by one compartment model is not accurate enough for research purposes, it seems to work well in routine clinical practice for the measurement of glomerular filtration rate using 99mTc-DTPA as a tracer substance. The performance is simple, it needs only a few blood samples, nor does it need any urine collection, the radiation dose is low and it seems to be more accurate than the endogenous creatinine clearance.

Adolescent↗